$2.78
Today
as of Sep 4, 16:48 ET
Last 30 days
Recent Press Releases & News
Decoy Therapeutics: Q2 Earnings Snapshot
Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform
Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence Global Health Threats
Overview
52-week range
$2.69
$71
0% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+5.6%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-4.46 | — | — | — | — | financials |
| Fri May 8, 2026 | Mar/2026 | $-4.18 | — | — | -305.8% | -0.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.81 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.45 | — | — | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-1.03 | — | — | — | +11.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-11.38 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-2.37 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-3.27 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-5.21 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-11.45 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-2.23 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $227,629 | — | — | — | $0 | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-3M | $-2M | — | $-895,130 | $-965,565 | $-2M | — | $-1M |
| Net income | $-2M | $-2M | — | $-873,467 | $-957,825 | $-2M | — | $-972,121 |
| EPS (diluted) | $-4.46 | $-4.18 | — | $-1.81 | $-81.21 | $-240.07 | — | $-11.38 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $8M | $8M | $11M | $5M | $794,886 | $2M | $2M | $3M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $9M | $8M | $11M | $6M | $1M | $2M | $3M | $4M |
| Total assets | $9M | $8M | $11M | $6M | $1M | $2M | $3M | $4M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $5M | $5M | $5M | $2M | $2M | $2M | $2M | $934,581 |
| Total equity | $4M | $4M | $6M | $4M | $-829,724 | $61,866 | $2M | $3M |
Implied volatility — last 90 days
No IV snapshots yet for DCOY.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.